A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Verastem, Inc.
Astellas Pharma Inc
AVEO Pharmaceuticals, Inc.
Alterome Therapeutics, Inc.
Erasca, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Tizona Therapeutics, Inc
Genentech, Inc.
Synthorx, Inc, a Sanofi company
Mirati Therapeutics Inc.
BioAtla, Inc.
MedImmune LLC
Immodulon Therapeutics Ltd
Hanmi Pharmaceutical Company Limited
Amgen
NKGen Biotech, Inc.
Eli Lilly and Company
Array BioPharma
Eli Lilly and Company
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
EMD Serono
Bristol-Myers Squibb
Eli Lilly and Company
Eli Lilly and Company